GLP-1 (glucagon-like peptide-1) receptor agonists work by helping regulate appetite, slow digestion, and support blood sugar balance
For those without coverage, we offer competitive self-pay pricing and assistance with manufacturer savings programs
Who qualifies The FDA-approved indications for GLP-1 weight-loss prescriptions: BMI 30 obesity classification BMI 27 with at least one weight-related condition hypertension, type 2 diabetes, dyslipidemia, obstructive sleep apnea, cardiovascular disease Beyond FDA labeling, physician judgment matters
Traditionally, type 2 diabetes mellitus (T2D) has been described by the triumvirate of: 1) impaired insulin secretion due to declining pancreatic -cell function
The company is exploring alternative methods of administering GLP-1 medications beyond injectables, with the goal of achieving scalable production to reach a wider population, says Karla Alczar, President and General Manager, Lilly Latin America, during Mexico Health Summit 2025.
Shareable Preview Images Every shared schedule includes an automatically generated preview image showing your drug concentration chart, perfect for sharing in forums, social media, or with healthcare providers